Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-27T00:28:10.066Z Has data issue: false hasContentIssue false

Do platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) have a predictive value on pediatric extracorporeal membrane oxygenation (ECMO) results?

Part of: Surgery

Published online by Cambridge University Press:  21 May 2021

Ergin Arslanoğlu
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Nihat Çine
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Kenan Abdurrahman Kara*
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Eylem Tunçer
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Fatma Ukil Işıldak
Affiliation:
Pediatric Cardiovascular Anesthesia and Reanimation Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Yasemin Yavuz
Affiliation:
Pediatric Cardiovascular Anesthesia and Reanimation Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Abdullah Arif Yılmaz
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Fatih Tomrukcu
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Cuneyt Arkan
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Fatih Yigit
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
Hakan Ceyran
Affiliation:
Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli Kavşağı, Turkey
*
Author for correspondence: K. A. Kara, Pediatric Cardiovascular Surgery Department, Kartal Kosuyolu High Education and Training Hospital, Cevizli, 2, Denizer Caddesi, Cevizli Kavşağı, 34865Kartal, İstanbul, Turkey. Tel: +9053006552251. E-mail: kenankaradoc@gmail.com

Abstract

Background:

It is difficult to predict the complications and prognosis of ECMO, which is gaining widespread use in patients with pediatric surgery. Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are emerging inflammatory markers that can be calculated from complete blood count, which is a cheap and easily accessible laboratory analysis. The ratios between cellular elements in peripheral blood have been demonstrated to provide information on inflammation, infection, and immune response.

Methods:

Sixty-seven patients who needed ECMO application after undergoing pediatric cardiovascular surgery in our clinic, between May 2005 and April 2020, were included in this study. The age of patients varied between 4 days and 17 years with a mean of 30.59 ± 147.26 months.

Results:

The relationships between PLR or NLR values and various blood parameters and blood gas results were found to be statistically nonsignificant in our group of pediatric ECMO recipients. Even if the effect of PLR and NLR values on mortality and prognosis is statistically nonsignificant in patients who need ECMO after congenital heart surgery, PLR and NLR are typically elevated in the postoperative period. An increase in these values above a certain threshold may be a statistically significant indicator for the prediction of mortality.

Conclusions:

There are few studies in the literature concerning PLR and NLR values in patients with pediatric heart surgery. We consider this study will make way for new studies in the future.

Type
Original Article
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kang, MH, Go, SI, Song, HN, et al. Te prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer. Br J Cancer 2014; 111: 452460.CrossRefGoogle Scholar
Zhao, J, Zhang, C, Liu, J, et al. Prognostic significance of Serum Cysteine-Rich protein 61 in patients with acute heart failure. Cell Physiol Biochem 2018; 48: 11771187.CrossRefGoogle ScholarPubMed
Lee, YSG, Baradi, A, Peverelle, M, et al. Usefulness of platelet-to-lymphocyte ratio to predict long-term all-cause mortality in patients at high risk of coronary artery disease who underwent coronary angiography. Am J Cardiol 2018; 121: 10211026.CrossRefGoogle ScholarPubMed
Balta, S, Ozturk, C Te platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets 2015; 26: 680681.CrossRefGoogle Scholar
Azab, B, Shah, N, Akerman, M, McGinn, JT. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Tromb Thrombolysis 2012; 34: 326334.CrossRefGoogle ScholarPubMed
Ozcan Cetin, EH, Cetin, MS, Aras, D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology 2016; 67: 336345.CrossRefGoogle ScholarPubMed
Cho, KI, Ann, SH, Singh, GB, Her, A-Y, Shin, E-S. Combined usefulness of the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention with a drug-eluting stent. PloS One 2015; 10: e0133934. https://doi.org/10.1371/journal.pone.0133934.CrossRefGoogle ScholarPubMed
Hudzik, B, Szkodzinski, J, Gorol, J, et al. Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction. Biomark Med 2015; 9: 199207.CrossRefGoogle ScholarPubMed
Kulik, TJ, Moler, FW, Palmisano, JM, et al. Outcome-associated factors in pediatric patients treated with extracorporeal membrane oxygenator after cardiac surgery. Circulation 1996; 94 (9 Suppl): II63II68.Google ScholarPubMed
Walters, HL, Hakimi, M, Rice, MD, Lyons, JM, Whittlesey, GC, Klein, MD. Pediatric cardiac surgical ECMO: multivariate analysis of risk factors for hospital death. Ann Thorac Surg 1995; 60: 329337.CrossRefGoogle ScholarPubMed
Montgomery, VL, Strotman, JM, Ross, MP. Impact of multiple organ system dysfunction and nosocomial infections on survival of children treated with extracorporeal membrane oxygenation after heart surgery. Crit Care Med 2000; 28: 526531.CrossRefGoogle ScholarPubMed
Aharon, AS, Drinkwater, DC Jr, Churchwell, KB, et al. Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions. Ann Thorac Surg 2001; 72: 20952102.CrossRefGoogle ScholarPubMed
Kolovos, NS, Bratton, SL, Moler, FW, et al. Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery. Ann Thorac Surg 2003; 76: 14351442.CrossRefGoogle ScholarPubMed
Ye, GL, Chen, Q, Chen, X, et al. The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: a cohort study. Sci Rep 2019; 9: 10639. doi: 10.1038/s41598-019-47143-2. PMID: 31337846; PMCID: PMC6650439.CrossRefGoogle Scholar
Can, E, Hamilcikan, Ş, Can, C. The value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio for detecting early-onset neonatal sepsis. J Pediatr Hematol Oncol 2018; 40: e229e232. doi: 10.1097/MPH.0000000000001059. PMID: 29219889.CrossRefGoogle ScholarPubMed
Sunbul, M, Gerin, F, Durmus, E, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014; 36: 217221.CrossRefGoogle ScholarPubMed
Oylumlu, M, Yıldız, A, Oylumlu, M, et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol 2015; 15: 277283.CrossRefGoogle ScholarPubMed
Kocas, C, Yildiz, A, Abaci, O, et al. Platelet-to-lymphocyte ratio predicts contrast-induced nephropathy in patients with non-ST-segment elevation acute coronary syndrome. Angiology 2015; 66: 964968.CrossRefGoogle ScholarPubMed
Kurtul, A, Murat, SN, Yarlioglues, M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol 2014; 114: 972978.CrossRefGoogle ScholarPubMed
Pourafkari, L, Wang, CK, Tajlil, A, Afshar, AH, Schwartz, M, Nader, ND. platelet-lymphocyte ratio in prediction of outcome of acute heart failure. Biomark Med 2018; 12: 6370.CrossRefGoogle ScholarPubMed
Huang, Z, Fu, Z, Huang, W, Huang, K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. Am J Emerg Med 2020; 38: 641647. doi: 10.1016/j.ajem.2019.10.023. Epub 2019 Nov 18. PMID: 31785981.CrossRefGoogle ScholarPubMed
Dong, CH, Wang, ZM, Chen, SY. Neutrophil to lymphocyte ratio predict mortality and major adverse cardiac events in acute coronary syndrome: A systematic review and meta-analysis. Clin Biochem 2018; 52: 131136. doi: 10.1016/j.clinbiochem.2017.11.008. Epub 2017 Nov 11. PMID: 29132766.CrossRefGoogle ScholarPubMed
Forget, P, Khalifa, C, Defour, JP, Latinne, D, Van Pel, MC, De Kock, M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes 2017; 10: 12. doi: 10.1186/s13104-016-2335-5. PMID: 28057051; PMCID: PMC5217256.CrossRefGoogle ScholarPubMed
Mısırlıoğlu, M, Bekdaş, M, Kabakuş, N. Platelet-lymphocyte ratio in predicting mortality of patients in pediatric intensive care unit. J Clin Anal Med 2018; 9: 488492.CrossRefGoogle Scholar
Dursun, A, Ozsoylu, S, Akyildiz, BN. Neutrophil-to-lymphocyte ratio and mean platelet volume can be useful markers to predict sepsis in children. Pak J Med Sci 2018; 34: 918922.CrossRefGoogle ScholarPubMed
Shah, SA, Shankar, V, Churchwell, KB, et al. Clinical outcomes of 84 children with congenital heart disease managed with extracorporeal membrane oxygenation after cardiac surgery. ASAIO J 2005; 51: 504507. doi: 10.1097/01.mat.0000171595.67127.74. PMID: 16322706.CrossRefGoogle Scholar
Kurtul, A, Ornek, E. Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review. Angiology 2019; 70: 802818. doi: 10.1177/0003319719845186. Epub 2019 Apr 28. PMID: 31030530.CrossRefGoogle ScholarPubMed
Savluk, OF, Guzelmeric, F, Yavuz, Y, et al. Neutrophil-lymphocyte ratio as a mortality predictor for Norwood stage I operations. Gen Thorac Cardiovasc Surg 2019; 67: 669676. doi: 10.1007/s11748-019-01081-y. Epub 2019 Feb 21. PMID: 30790236.CrossRefGoogle ScholarPubMed
Ergün, Servet. Use of a new extracorporeal membrane oxygenator system and first experiences. Dicle Tıp Dergisi 2020; 47: 755–762.CrossRefGoogle Scholar